A high red blood cell (RBC) count means your blood contains more oxygen-carrying cells than normal. For men, the typical range is 4.7 to 6.1 million cells per microliter; for women, it’s 4.2 to 5.4 million. Anything above those ranges is considered elevated, a condition broadly called erythrocytosis. The causes range from something as simple as dehydration to serious blood disorders, and understanding which category you fall into determines what happens next.
Dehydration: The Most Common Cause
Sometimes a high RBC count isn’t actually about having too many red blood cells. It’s about not having enough liquid in your blood. When you’re dehydrated, the fluid portion of your blood (plasma) drops, which concentrates the red blood cells you already have. The count looks high on a lab report, but your body hasn’t produced any extra cells. This is called relative erythrocytosis.
Vomiting, diarrhea, heavy sweating, and medications like diuretics can all reduce plasma volume enough to push your RBC count above normal. In most cases, rehydrating brings the numbers back down quickly. If your doctor suspects dehydration is the explanation, they may ask you to drink fluids and retest before pursuing further workup.
Low Oxygen Levels
Your body has a built-in feedback system: when tissues aren’t getting enough oxygen, your kidneys release a hormone called erythropoietin (EPO), which tells your bone marrow to make more red blood cells. This is a normal, adaptive response, but it can push your count above the reference range if the oxygen shortage is ongoing.
Several common situations trigger this response. Living at high altitude exposes you to thinner air with less oxygen, and your body compensates by producing more RBCs over weeks to months. Chronic lung diseases like COPD reduce how efficiently your lungs transfer oxygen into your blood. Obstructive sleep apnea causes repeated drops in oxygen throughout the night. Research shows that this intermittent oxygen deprivation stabilizes proteins in the body that switch on EPO production, stimulating red blood cell production even though oxygen levels recover between episodes.
Smoking is another major trigger. Carbon monoxide from cigarette smoke binds to hemoglobin far more tightly than oxygen does, effectively reducing your blood’s oxygen-carrying capacity. Your body responds by manufacturing more red blood cells to compensate. Smokers frequently show elevated RBC counts that normalize after quitting, though this can take months.
Testosterone and Anabolic Steroids
Testosterone therapy is one of the most common medication-related causes of high RBC counts. Testosterone stimulates red blood cell production through multiple pathways, including lowering levels of hepcidin, a hormone that normally locks away iron. With more iron available, the bone marrow has the raw material it needs to ramp up production. Studies have found that hematocrit (the percentage of blood volume occupied by red blood cells) increases within one month of starting testosterone and continues rising after three months in a dose-dependent pattern: higher doses produce higher counts.
This applies to prescription testosterone replacement therapy and to anabolic steroids used for performance enhancement. It’s one reason routine blood work is recommended for anyone on testosterone, since the thickening effect on blood raises the risk of clots.
Polycythemia Vera
Polycythemia vera (PV) is a blood cancer in which the bone marrow overproduces red blood cells on its own, without any external trigger. In roughly 95% of cases, it’s driven by a specific genetic mutation called JAK2 V617F, where a single amino acid change in the JAK2 gene leaves a growth signal permanently switched on. The bone marrow keeps churning out red blood cells regardless of how much oxygen the body actually needs.
Doctors consider PV when hemoglobin rises above 16.5 g/dL in men or 16 g/dL in women, alongside a positive JAK2 mutation test. A bone marrow biopsy can confirm the diagnosis. PV is relatively rare, but it’s important to identify because untreated, the thickened blood significantly raises the risk of heart attack, stroke, and other clotting events. Treatment typically involves periodic blood draws to keep the red cell count in a safer range, sometimes combined with medication to slow marrow production.
Tumors That Produce EPO
Certain tumors can hijack the body’s oxygen-sensing system by producing erythropoietin on their own. Kidney cancer (renal cell carcinoma) is the best-known example, though fewer than 5% of kidney cancer patients develop this complication. Liver cancer and a type of brain tumor called cerebellar hemangioblastoma can also secrete EPO. Even noncancerous growths like kidney cysts have been documented as sources.
In these cases, the elevated RBC count is essentially a side effect of the tumor. Treating or removing the tumor typically brings the count back to normal.
Heart and Kidney Conditions
Congenital heart defects that mix oxygen-rich and oxygen-poor blood can leave the body chronically short on oxygen, triggering the same EPO-driven response seen with lung disease. Kidney disease can also occasionally cause erythrocytosis, particularly when cysts or tumors in the kidney produce excess EPO. These causes are less common but worth investigating when more typical explanations have been ruled out.
Symptoms of a High RBC Count
Mild elevations often cause no symptoms at all and are discovered incidentally on routine blood work. As the count climbs higher, blood becomes measurably thicker, which slows circulation and can produce a range of symptoms: headaches, blurry vision, fatigue, shortness of breath, joint pain, itchy skin (especially after a warm shower), numbness or tingling in the hands and feet, and nosebleeds.
The most serious risk is blood clots. Thicker blood moves more slowly and is more prone to clotting, which can lead to deep vein thrombosis, pulmonary embolism, stroke, or heart attack. This is why persistently elevated RBC counts are taken seriously even when symptoms are mild. The goal of treatment, regardless of the underlying cause, is to reduce blood viscosity enough to lower that clotting risk.